Skip to main content

Table 2 Primary and secondary outcome measures

From: Mid term freedom from atrial fibrillation following hybrid ablation, a systematic review and meta analysis

Study

Year

Follow up duration

Standard dev

# of patients initlally

Freedom from AF

Freedom from AF off AAD

Death

Emergent reopening

Phrenic nerve palsy

Stroke

Major complications

Bisleri et al [16]

2012

28.4(mean)

1.7

45

40/45 (88.9%)

NR

0

0

0

0

0

Bulava et al [17]

2017

24 (final)

0

70

64/67 (95.5%)

NR

0

2/70

7/10

0

9/70 (12.8%)

De Asmundis et al [18]

2019

24.9 (mean)

11.8

51

35/51 (68.6%)

35/51 (68.6%)

0

0

0

0

6/51 (11.8%)

Dunnington G. et al [19]

2021

36 (final)

0

451

104/145 (72%)

96/145 (66%)

7/461

4/455

6/455

2

28/461 (6.1%)

Edgerton et al [20]

2016

24 (final)

0

24

4/21 (19%)

NR

3/24

0/24

1/24

2

5/24

Gersak et al [21]

2016

48 months (final)

0

76

18/28 (64%)

25/36 (69%)

2/76

0

0

0

9/76 (11.8%)

Hwang et al [22]

2018

25.2 (median)

IQR 1.2–3.2

72

43/61 (70.4%)

NR

0

0

0

0

0

Jan et al [23]

2018

30.5 (mean)

6.9

50

19/25 (76%)

14/25 (58.3%)

0

1/24

0

0

3/24

Kim et al [24]

2021

24 months (final)

0

81

55/81 (67.8%)

NR

0

0

0

0

7/81

Maclean et al [25]

2020

30.5 (mean)

13.3

43

25/43 (58.1%)

14/43 (32.6%)

0

1/43

1/43

0

5/43

Maesen et al [26]

2018

36 months (final)

0

64

50/63 (79%)

44/57 (77%)

0

0

0

0

3/63

Magni et al [27]

2021

24 (final)

0

49

33/49 (67%)

NR

0

1/49

2/49

0

2/49

Ma et al [28]

2021

26 (mean)

13.5

40

34/40 (85%)

NR

0

0

0

0

0

Muneretto et al [29]

2012

30 (mean)

NR

36

33/36 (91.6%)

28/36 (77.7%)

0

0

0

0

0

Pojar et al [30]

2019

24 months

0

65

57/65 (87.7%)

NR

0

0

1/65

0

1/65

Tan et al [31]

2021

29 (mean)

12

50

35/50 (70%)

35/50 (70%)

0

0

0

0

6/50